Sitagliptin and Fractures in Type 2 Diabetes: A Nationwide Population-Based Propensity-Matching Study

Background: Sitagliptin, a dipeptidyl peptidase-4 inhibitor possibly affects bone turnover. We conducted this cohort study to determine whether sitagliptin is associated with an increased risk of fracture. Methods: The sitagliptin cohort included 1,578 patients aged 20 years and above. The nonsitagl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Shih-Yi, Hsu, Wu-Huei, Lin, Cheng-Chieh, Lin, Cheng-Li, Tsai, Chun-Hao, Yeh, Hung-Chieh, Hsu, Chung-Y., Kao, Chia-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025224/
https://www.ncbi.nlm.nih.gov/pubmed/29988467
http://dx.doi.org/10.3389/fphar.2018.00677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025224/
https://www.ncbi.nlm.nih.gov/pubmed/29988467
http://dx.doi.org/10.3389/fphar.2018.00677

Ejemplares similares